Objective: The aim of the study was to evaluate the impact of spinal cord injury on seminal plasma PSA concentration. Material: Semen obtained from normal controls (n=20) and patients (n=16) with spinal cord injury. Results: The concentration of prostate speci®c antigen in seminal plasma depended on the level of spinal cord injury, with signi®cantly lower concentrations in patients with spinal cord lesions below T7 compared to both normal age-matched controls (P=0.007) and patients with spinal cord injuries at or above T7 (P=0.017).
Introduction
Prostate speci®c antigen (PSA) was ®rst isolated from human seminal plasma. 1 PSA is produced almost exclusively in the prostate epithelium and is normally regarded as an indicator of the activity in the prostate gland. Furthermore, changes in PSA measured in serial serum samples correlate to the development of prostatic disease. 2 Prostate development and growth depends on normal androgen supply. 3 In vitro studies in animal models suggest that sympathetic activity may induce growth and/or maintain cell survival in the prostate 4 and human prostate cancer cell proliferation is inhibited by alphaadrenergic blocking agents. 5 The aim of this study was to evaluate the seminal plasma PSA concentrations in patients with spinal cord injuries (SCI) compared to normal controls, and to evaluate the impact of level of spinal cord injury on seminal plasma PSA-concentration.
Material and methods
Semen was obtained from 20 normal, healthy and fertile controls following masturbation and 16 SCI patients undergoing either vibratory or electrostimulation to induce ejaculation as described by Sùnksen et al 6 and Ohl et al. 7 Details about the patients included are given in Table 1 . Before assisted ejaculation procedures a urine culture was performed in all SCI patients. Semen was frozen at 7208C within 30 min after ejaculation. For PSA measurement, semen was diluted (1 : 10 000 or 1 : 100 000) in PSA-negative female serum and analyzed with the automated PSA method from Abbott Labs., Abbott Park, IL 8, 9 performed on an AxSYM (Abbott). 10 Follicle stimulating hormone (FSH), luteinising hormone (LH) and testosterone levels were measured in SCI patients, but not in controls. Seminal plasma PSA concentrations were compared using the Mann-Whitney rank sum test. Pvalues less than 0.05 are considered signi®cant.
Results
The age and seminal plasma PSA concentrations in controls and SCI patients are shown in Table 2 . No signi®cant dierences in age, completeness of SCI, or time since injury were found between patients with spinal cord lesions at or above T7 compared to lesions below T7. All SCI patients had normal FSH, LH and testosterone levels. No SCI patients had signi®cant bacterial growth in the urine before the ejaculation procedures.
The seminal plasma PSA concentrations were lower in patients with SCI compared to normal age-matched controls, however the dierence did not reach a signi®cant level, (P=0.08). No dierence in seminal plasma PSA was found between patients with lesions at or above T7 and normal controls.
Seminal plasma PSA concentrations in patients with lesions below T7 were signi®cantly lower than concentrations found in controls, (P=0.007), and in patients with lesions at or above T7, (P=0.017). No signi®cant dierences in seminal plasma PSA concentrations were found, when comparing ejaculates obtained by either vibratory or electrostimulation.
Discussion
PSA is secreted in high concentrations by the epithelium in the prostate, and is involved in the liquefaction of the seminal coagulum formed at ejaculation. 11 Seminal plasma PSA concentration is approximately 10 5 ± 10 6 times higher than PSA concentration in serum and the majority of PSA in seminal plasma is present in the catalytically active single-chain form. 12 Prostate growth and development of prostatic diseases depends on age and androgen supply. 3 Other factors, however, may modify the impact of androgens, such as a low 5-alpha-reductase activity found in Japanese men, which may be part of the explanation for the lower prostate cancer incidence in Japan. 13 The prostate normally contains a number of neuroendocrine cells and it has been suggested, that neuroendocrine stimulation may aect prostate growth and dierentation. 14, 15 The number of neuroendocrine cells in the prostate is increased in benign prostatic hyperplasia compared to normal glands. 14 Further, neuroendocrine cells can be found in the majority of prostatic carcinomas. 15 The neuroendocrine cells are often found in close relation to aerent nerves and produce a number of bioactive hormone-related substances of which some act as growth stimulators, 16 while others like somatostatin can inhibit trophic or growth factor activity. 15 The neurogenic stimulation of the male accessory sexual glands including the prostate arises from sympathetic nerves from the thoracolumbar spinal cord (T11 ± L2) and from parasympathetic nerves from the sacral spinal cord (S2 ± 4). 17, 18 When analyzing the impact of the SCI level we found seminal plasma PSA concentrations to be signi®cantly lower in patients with lesions below T7 compared to patients with lesions at or above this level. More logically a spinal cord cut-o level at T10 would have been expected. However, previously it has been demonstrated, that seminal somatostatin levels in patients with SCI depended on the level of spinal cord injury, with signi®cantly higher levels in patients with lesions below T6. 19 This ®nding suggests that the neurogenic stimulation of somatostatin is dependent on nerve ®bres arising above this level. In addition, semen analyses from SCI men have demonstrated significantly better sperm motility in patients with lesions at or above T6 compared to lesions below this level. 20 PSA is in our study lower, although not signi®cantly, in patients with spinal cord injuries compared to healthy controls. It is noteworthy that patients with normal testosterone levels and SCI below T7 had signi®cantly lower seminal PSA than both normal controls and SCI patients with lesions at or above T7. This ®nding suggests that some neurogenically mediated factor plays a role in the PSA production. The inverse correlation between high somatostatin and low seminal plasma PSA concentrations found in patients with spinal cord lesions below the level of T6/ T7 suggests that this spinal cord level represents a crucial point in the neurogenic stimulation of the prostate gland.
PSA has been demonstrated to degrade, when serum samples are stored. 21 Most likely a similar degradation will occur in seminal plasma when these samples are stored. The observed dierence found in seminal plasma PSA concentration, however, is unlikely to be explained by storage, as the handling of samples were identical in the two groups. Serum PSA concentration increases in patients with urinary retention, lower urinary tract infections, and prostatitis, 22, 23 conditions frequently present in patients with SCI. The impact of these conditions on seminal plasma PSA has not been elucidated. However, if seminal plasma PSA were to increase, this would tend to diminish the dierence in 24 To what extent seminal plasma PSA concentration varies is not known, and studies including more patients and repeated measurements are ongoing.
Further studies on the possible eect of neurogenic stimulation of prostatic development and growth are warranted, and may possibly add to our understanding of both neuroendocrine dierentiation and aetiological factors in the development of prostatic diseases.
